Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

E2F-1 transcription factor is overexpressed in oxyphilic thyroid tumors.

Marco Volante1, Sabrina Croce, Carla Pecchioni

  • 1Department of Biomedical Sciences and Oncology, University of Turin, Torino, Italy.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|October 16, 2002
PubMed
Summary

E2F-1 is expressed in all thyroid tumors, with higher levels in oxyphilic types. This suggests E2F-1 may be linked to apoptosis rather than proliferation in these specific thyroid neoplasms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuroendocrine Tumors of the Gallbladder: A Multicenter Case Series and Systematic Literature Review Indicating Predominantly Non-Aggressive Tumor Behavior and a Common Association with Cholesterol Polyps and Cholesterolosis.

Endocrine pathology·2026
Same author

Mixed/combined pulmonary non-small cell carcinoma and carcinoid: State-of-the-Art review of clinical, histological, and molecular features with therapeutic implications.

Histology and histopathology·2026
Same author

Three-Tier Prognostic Stratification of Lung Carcinoids (NET G1-G2-G3) by Multivariable, Data-Driven Integration of Ki-67 and Mitotic Count.

Endocrine pathology·2026
Same author

Analysis of histological parameters of aggressiveness in resected lung squamous cell carcinoma.

Pathologica·2026
Same author

European Society of Neuroendocrine Tumors (ENETS) 2025 guidance paper for lung and thymic carcinoids.

Journal of neuroendocrinology·2026
Same author

Unraveling lung cancer dynamics: a new metabolic signature improving the prediction of recurrence in resected lung adenocarcinoma.

Journal of translational medicine·2026

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Cell cycle regulators are frequently altered in thyroid tumors.
  • E2F transcription factors, particularly E2F-1, are key regulators of the retinoblastoma pathway and apoptosis, but their role in thyroid neoplasms is unknown.

Purpose of the Study:

  • To investigate the expression of E2F-1 in various thyroid tumors.
  • To correlate E2F-1 expression with other cell cycle proteins and tumor characteristics.

Main Methods:

  • Immunohistochemistry was used to analyze E2F-1 expression in 73 thyroid tumors (28 oxyphilic, 45 nonoxyphilic).
  • Expression of p27, Ki-67, pRb, and p53 was also assessed.
  • Statistical analysis was performed to correlate findings.

Related Experiment Videos

Main Results:

  • E2F-1 was expressed in all thyroid tumor types, benign and malignant.
  • Oxyphilic adenomas and carcinomas showed significantly higher E2F-1 expression compared to nonoxyphilic lesions.
  • E2F-1 expression did not correlate with proliferation, except in anaplastic carcinoma, and was high in oxyphilic tumors with low proliferative indices.

Conclusions:

  • E2F-1 is widely involved in thyroid tumorigenesis, affecting both benign and malignant neoplasms.
  • In oxyphilic thyroid tumors, elevated E2F-1 expression may be associated with proapoptotic functions rather than cell proliferation.